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We investigated the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) serological 
markers of infection in young adults from the metropolitan region of Florianópolis who were conscripts 
of the Air Base of Florianópolis in the state of Santa Catarina, Brazil. A population-based cross-sectional 
seroprevalence study was conducted with 371 young males during a one year period starting in June 2009. 
Demographic characteristics, socio-economic characteristics and possible risk factors to HBV and HCV 
were assessed. Blood samples were analyzed for HBsAg, anti-HBc, anti-HCV and anti-HBs through 
automated microparticle enzymatic immunoassays (Abbott®, AxSYM System, Wiesbaden, Germany). 
None of the participants showed positivity to HBsAg or anti-HCV. The prevalence of anti-HBc was 1.6% 
(95% CI 0.6 – 3.5), and the prevalence of anti-HBs was 40.7% (95% CI 35.7 – 45.9). Unsafe sex was 
associated with positive anti-HBc in a bivariate analysis. There was a very low prevalence of past HBV 
infection and no cases of past HCV infection in a young adult population in the metropolitan region of 
Florianópolis. The very low prevalence of markers of infection and risk factors indicates a very optimistic 
future with respect to HBV and HCV infection in this population.
Uniterms: HBV. HCV. Hepatitis B. Hepatitis C. Seroprevalence.
Este estudo teve como objetivo investigar a prevalência dos marcadores sorológicos de infecção pelo 
HBV e HCV em adultos jovens na Região Metropolitana de Florianópolis, conscritos da Base Aérea 
de Florianópolis, Santa Catarina, Brasil.  Trata-se de um estudo soroepidemiológico transversal de 
base populacional com 371 adultos jovens, no período de um ano a partir de junho de 2009. Foram 
pesquisadas características sócio-econômicas e possíveis fatores de risco para HBV e HCV. As amostras 
de sangue foram analisadas quanto à presença de HBsAg, anti-HBc, anti-HCV e anti-HBs pelo método 
imunoensaio enzimático automatizado de micropartículas (Abbott®, Sistema AxSYM, Wiesbaden, 
Alemanha). Nenhum dos participantes demonstrou positividade para HBsAg ou anti-HCV. A prevalência 
do anti-HBc foi de 1,6% (IC 95% 0,6 – 3,5) e do anti-HBs foi 40,7% (IC 95% 35,7 – 45,9). Relação 
sexual desprotegida associou-se com a positividade do anti-HBc na análise bivariada.  Demonstrou-se 
prevalência muito baixa de infecção passada pelo HBV e ausência de HCV nesta população de adultos 
jovens na Região Metropolitana de Florianópolis. A particularidade desta prevalência muito baixa de 
marcadores de infecção e fatores de risco aponta para um quadro otimista em relação ao HBV e HCV 
no futuro para esta população.
Unitermos: HBV. HCV. Hepatite B. Hepatite C. Soroprevalência.
INTRODUCTION
Infections with hepatitis B virus (HBV) and hepatitis 
C virus (HCV) are still major public health problems and 
represent significant causes of morbidity and mortality 
worldwide. Despite the recent development of vaccines 
and pharmacological treatment alternatives, such infec-
tions increase the risk of hepatic decompensation, cirrhosis 
and hepatocellular carcinoma (WHO, 2002).
The World Health Organization (2009) estimates 
that, currently, more than two billion people worldwide 
have been infected with HBV, and of these people, ap-
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proximately 360 million are chronically infected. For 
HCV, estimates indicate that 3 to 4 million people are 
infected annually and that there are 170 million chronic 
carriers worldwide (WHO, 1999).
In Brazil, a recent partnership between the Ministry 
of Health, through the National Program of Viral Hepa-
titis, the Municipal and State Health Secretariats and the 
federal universities has resulted in the Brazilian National 
Survey of Viral Hepatitis project, which is currently in its 
final stage. The project is investigating the true picture of 
the disease in the country by investigating the population 
from 10 to 69 years old in 27 Brazilian cities (Ximenes 
et al., 2010). Nevertheless, there are still few studies that 
address the general population.
In Brazil, the wide territory and cultural and eco-
nomic differences influence the unequal distribution of 
hepatitis B and C throughout the country (MS, 2008).
Additionally, prevalence studies of HBV and HCV 
markers in South Brazil, more specifically in the state of 
Santa Catarina, are scarce. Although a recent study has 
determined such prevalences in 10- to 16-year-old stu-
dents in the metropolitan region of Florianópolis (MRF), 
the prevalences of HBV and HCV in the population born 
prior to the HBV vaccine implementation in the state 
remain unknown.
Hepatitis B vaccination began in 1989 in some 
regions of Brazil and was primarily directed to specific 
groups. Some years later (1998), it became available in 
more regions and to both children aged below 1 year and 
high-risk populations. Afterwards, the coverage of the 
vaccine was extended to students in health-related fields, 
military personnel and adolescents up to 15 years old. 
Specifically in Santa Catarina, the vaccination was rec-
ommended to children aged below 4 years in 1993, and 
this recommendation increased to include children up to 
15 years old in 1996. In 2001, the National Immunization 
Program was extended to the population up to 19 years 
old (MS, 2003).
Because awareness of the epidemiologic profile and 
risk factors in the population is crucial for establishing and 
evaluating health political programs, there is an urgent 
need to determine these profiles.
Therefore, the aim of this study was to investigate 
the prevalence of HBV and HCV serological markers in 
young adults of the MRF, who were conscripts of the Air 
Base of Florianópolis in the state of Santa Catarina, Brazil.
PATIENTS AND METHODS
This population-based cross-sectional seropreva-
lence study included young males, who were residents of 
the MRF and conscripts of the Brazilian Air Force at the 
Air Base of Florianópolis, during a 1-year period begin-
ning in June 2009. Military service is mandatory in Brazil, 
and every male must enroll for service at the selection 
commission in the year he turns 18, regardless of schooling 
and socio-economic level. Each commission is responsible 
for assessing the conscripts residing in the given region, 
based on the number of inhabitants of the location.
All conscripts were invited to participate in the study 
upon their arrival at the air base, before any evaluation or 
test, to minimize selection bias.
A total of 371 individuals (90.5% of all conscripts) 
consented to participate in the study, and this sample was 
considered to be sufficient to determine a prevalence of 
HBV and HCV markers from 0 to 40% with a 95% confi-
dence interval (CI) and 0.05 alpha error (Motta, Wagner, 
2003).
Approval for the study was obtained from the Ethics 
Committee of the Federal University of Santa Catarina 
(protocol 136/2009), and all subjects were enrolled after 
providing written informed consent.
A self-administered standard questionnaire, adapted 
from one that was previously established and tested 
(Ximenes et al., 2010), was administered to each subject 
to identify socio-demographic characteristics (age, eth-
nicity, marital status, education level of the subjects and 
their parents, residency, occupation and family monthly 
income) and possible HBV- and HCV-related risk factors 
(history of hepatitis for the subjects and their families, 
hospitalization, blood transfusion, tattoos or piercings, 
intravenous drug use, unsafe sex, men who have sex with 
men and history of sexually transmitted diseases).
Following the questionnaire, blood samples were 
obtained from all enrolled subjects and stored at –20°C 
until transportation to the Laboratory of Clinical Analysis 
of the University Hospital of the Federal University of 
Santa Catarina.
Serology comprised HBsAg, anti-HBc, anti-HBs 
and anti-HCV, and every test was performed using auto-
mated microparticle enzymatic immunoassays (Abbott®, 
AxSYM System, Wiesbaden, Germany). HBsAg, anti-
HBc and anti-HCV results were categorized as “positive” 
or “negative” according to the provided cut-offs, and anti-
HBs titers were categorized as “undetectable” (anti-HBs 
< 10 mIU/mL) and “reactive” (anti-HBs ≥ 10 mIU/mL), 
according to the manufacturer’s instructions. Samples with 
positive or borderline results for any marker of infection 
were retested, and all remaining borderline and indeter-
minate results were tested using automated chemilumi-
nescent magnetic microparticle immunoassay (Abbott®, 
ARCHITECT System, Wiesbaden, Germany).
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Positive cases were referred to the nearest health 
care center to perform confirmatory tests and receive 
further counseling and monitoring.
Descriptive statistics consisted of the character-
ization of the studied population (socio-demographic 
characteristics) and the assessment of HBV and HCV risk 
factors through the respective percentages and median and 
standard deviation (SD) for continuous variables.
The bivariate analysis consisted of Pearson’s Chi-
square test to compare categorical values, with a signifi-
cance level of P < 0.050. For the multivariate analysis, 
non-conditional logistic regression was used to identify 
associations between participant socio-demographic char-
acteristics, possible risk factors and anti-HBc status. This 
model included variables that were significant at P < 0.200 
in Pearson’s Chi-square test. All reported values are two-
tailed. The dependent variable was anti-HBc status, and 
the independent variables were residency, family monthly 
income and unsafe sex.
Results are presented as the odds ratio (OR) and the 
respective 95% CI and P value. Unadjusted OR (UOR) 
refers to univariate logistic regression analysis, and ad-
justed OR (AOR) refers to multivariate logistic regression 
analysis.
All data were entered into and analyzed using SPSS 
version 11.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
The majority of the participants were 18 years old 
(80%), white (71%) and single (85%) (Table I). Most were 
attending or had completed high school (92%) and lived 
in the capital city of Florianópolis (64%).
TABLE I - Demographic and socio-economic characteristics of young adults in South Brazil by anti-HBc status
Variable
Anti-HBc
P TotalPositive Negative
n % n % n %
Total 6 1.6 364 98.4 371 100.0
Age (years old)a
     18 4 1.3 293 98.7 0.408 297 80.1
     19 2 2.7 72 97.3 74 19.9
Ethnicity
     White 5 1.9 260 98.1 0.515 265 71.4
     Brown/Black 1 0.9 105 99.1 106 28.6
Marital status
     Married/in a relationship 1 1.8 56 98.2 0.929 57 15.4
     Single/no relationship 5 1.6 309 98.4 314 84.6
Education
    ≤ Elementary school 1 3.4 28 96.6 0.606 29 7.8
    < High school 1 0.9 111 99.1 112 30.2
    ≥ High school 4 1.7 226 98.3 230 62.0
Parents’ education
    ≤ Elementary school 3 2.2 134 97.8 0.517 137 36.9
    ≤ High school 3 1.7 169 98.3 172 46.4
    > High school 0 0.0 62 100.0 62 16.7
Residency
     Capital city of Florianópolis 2 0.8 235 99.2 0.116 237 63.9
     Other cities of the MRF 4 3.0 130 97.0 134 36.1
Employed
     Yes 4 2.0 199 98.0 0.553 203 54.7
     No 2 1.2 166 98.8 168 45.3
Familiar monthly incomeb
     1 – 4 2 0.9 217 99.1 0.197 219 59.0
     5 or more 4 2.6 148 97.4 152 41.0
a Mean and median age – 18 ± 0.5 (95% CI 18.2–18.3).
b Brazilian minimum wage – R$ 510.00 (approximately US$ 300.00)
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None of the participants showed positivity to HBsAg 
or anti-HCV. The prevalence of anti-HBc in the studied 
population was 1.6% (95% CI 0.6 – 3.5) and of anti-HBs 
was 40.7% (95% CI 35.7 – 45.9). Four of the six positive 
anti-HBc subjects were anti-HBs reactive.
Table II shows the results of the HBV possible risk 
factors assessment. Unsafe sex was significantly associ-
ated with positive anti-HBc (P = 0.040).
Age, ethnicity, marital status, education, parents’ 
education, occupation, history of hepatitis for the subjects 
and their families, hospitalization, blood transfusion, tat-
toos or piercings, intravenous drug use, men who have 
sex with men and history of sexually transmitted diseases 
were not significantly associated with anti-HBc (P > 0.2) 
in the bivariate analysis.
The association between unsafe sex and anti-HBc 
[UOR 7.2 (0.8 – 62.3)] in the logistic regression analysis 
was inconclusive (P = 0.077) (Table III).
Residency [AOR 3.6 (0.6 – 20.1)], family monthly 
income [AOR 2.6 (0.5 – 14.8)] and unsafe sex [AOR 6.7 
(0.8 – 58.4)] had no statistically significant association 
with anti-HBc in the multivariate regression model.
TABLE II - Possible risk factors related to HBV infection in young adults in South Brazil by anti-HBc status
Variable
Anti-HBc
P
Total
Positive Negative
n % n % n %
Total 6 1.6 364 98.4 371 100.0
History of hepatitis
     Yes 0 0.0 5 100.0 0.955 5 1.3
     No 5 1.6 305 98.4 310 83.6
     Unknown 1 1.8 55 98.2 56 15.1
Family history of hepatitis 
     Yes 6 1.8 324 98.2 0.384 41 11.1
     No 0 0.0 41 100.0 330 88.9
Hospitalization
     Yes 3 2.7 110 97.3 0.294 113 30.5
     No 3 1.2 255 98.8 258 69.5
Blood transfusion
     Yes 0 0.0 5 100.0 0.810 5 1.3
     No 6 1.7 341 98.3 347 93.6
     Unknown 0 0.0 19 100.0 19 5.1
Piercings or tattoos 
     Yes 2 2.0 96 98.0 0.698 98 26.4
     No 4 1.5 269 98.5 273 73.6
Intravenous drug use
     Yes 0 0.0 5 100.0 0.773 5 1.3
     No 6 1.6 360 98.4 366 98.7
Unsafe sex
     Yes 5 3.2 152 96.8 0.040 157 42.3
     No 1 0.5 213 99.5 214 57.7
Men who have sex with men 
     Yes 0 0.0 1 100.0 0.898 1 0.3
     No 6 1.6 364 98.4 370 99.7
History of sexually transmitted diseases
     Yes 0 0.0 1 100.0 0.898 1 0.3
     No 6 1.6 364 98.4 370 99.7
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TABLE III - Multivariate non-conditional logistic regression analysis between variables significant at P < 0.2 in bivariate analysis 
and anti-HBc status
Anti-HBc rate % 
(n/N)
UOR 
(95% CI) P
AOR 
(95% CI) P
Residency
   Florianópolis 0.8 (2/237) 1 0.141 1 0.149
   MRF 3.0 (4/134) 3.6 (0.7–20.0) 3.6 (0.6–20.1)
FMI
   1-4 0.9 (2/219) 1 0.218 1 0.275
    5 or more 2.6 (4/152) 2.9 (0.5–16.0) 2.6 (0.5–14.8)
Unsafe sex
    Yes 3.2 (5/157) 7.0 (0.8–60.6) 0.077 6.7 (0.8–58.4) 0.086
    No 0.5 (1/214) 1 1
FMI, family monthly income
DISCUSSION
The main findings of this study were the low preva-
lence of HBV serological markers of infection in young 
males who were born prior to the implementation of the 
vaccination against hepatitis B in this region, which is 
highly comparable to that of children and adolescents in 
the same region, from 10- to 16-year-old with a high im-
munization rate (90%), (HBsAg (0%) and anti-HBc [0.5% 
(95%CI 0.1 – 1.9)]) (Voigt et al., 2010).
In accord with the National Health and Nutritional 
examination survey, anti-HBc positivity alone indicates 
past contact with the virus, and the negative HBsAg in all 
cases demonstrates that the virus had already been cleared 
from the organism (McQuillan et al., 1999). Although only 
two of the six anti-HBc positive individuals had reactive 
anti-HBs, the anti-HBs titers may have waned through the 
years, becoming undetectable despite past contact with 
the virus (Zanetti et al., 2005; Hammitt et al., 2007; But 
et al., 2008). Alternatively, these four cases may represent 
false positive cases, the “window phase” of an acute HBV 
infection or an unresolved chronic HBV infection with low 
grade, possibly intermittent virus production and detect-
able serum or liver HBV-DNA (Knoll et al., 2006).
The anti-HBc prevalence found in our study is also 
very similar to the prevalence found by the Brazilian Na-
tional Survey of Viral Hepatitis in the investigation of viral 
hepatitis in the northeast region, the central region and the 
federal district from 2004 to 2005 among 13- to 19-year-
old non-vaccinated (3.5%, 2.2% and 1.6%, respectively) 
and vaccinated (1.3%, 1.5% and 1.3%, respectively) in-
dividuals (Pereira et al., 2009).
Additionally, this prevalence is also similar to the 
rate found in adolescents with immunization rates up to 
98% in the state (1.4% and 0.6%) (Scaraveli et al., 2011; 
Tonial et al., 2011), the rate reported in Portugal for ado-
lescents with a mean age of 14 years old (0.6%) (Antunes, 
Macedo, Estrada, 2004), and the rate reported in Italy for 
individuals up to 24 years old (1.0%) (Fabris et al., 2008); 
however, it is inferior to the rate reported by Nascimento 
et al. (2008) in first-time eligible blood-donors from north, 
northeast and southeast Brazil (2.9%) and to the rate found 
in blood donors in south Brazil (15.6%) (Martelli et al., 
1999) and the MRF (4.5%) (Rosini et al., 2003).
These low prevalences found in this study may 
reflect low HBV circulation among subjects in young 
adulthood, probably due to the recent vaccination efforts 
(2001) in infants and adolescents up to 20 years old in 
Brazil, the success of which is supported by the anti-HBs 
prevalence rate found in this study. This rate, although 
lower, is similar to the rate in Greece (62.2%) in 17- to 
34-year-olds (German et al., 2006) and higher than the 
rate in the USA (31.5%) in 18- to 35-year-olds (Scott et 
al., 2005); both studies utilized military recruits and took 
place 10 years after mandatory hepatitis B immunization 
was established. As previously mentioned, anti-HBs titers 
may have decreased over the years, thus suggesting that 
many more than 40.7% of the subjects may be immunized.
Analysis of these data allows one to observe a fur-
ther reduction in anti-HBc seroprevalence among adults 
in South Brazil during the last decade. Additionally, when 
compared to seropositivity for HBsAg of 2.6% among 
1,006 Brazilian Army conscripts in 2002 (Toledo et al., 
2005), our results document a significant reduction in 
HBsAg seroprevalence, reinforcing the observation that 
the HBV seroprevalence has significantly decreased after 
the establishment of hepatitis B vaccination.
Although low rates of HBV infection are expected 
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in infants and adolescents as a consequence of high im-
munization rates, low virus circulation and little exposure 
to risk factors based on the young age, young adults aged 
18 and 19 years are expected to be exposed to a wide range 
of risk behaviors.
In the analysis of possible risk factors, unsafe sex 
was significantly associated with anti-HBc in the bivari-
ate analysis, in agreement with other seroepidemiological 
studies. This finding reinforces the importance of safe 
sex and education to safe sexual behavior as a powerful 
prevention tool.
Unlike other studies, we did not find significant as-
sociations between anti-HBc and some well-documented 
risk factors, such as tattoos, piercings, sexually transmitted 
diseases and intravenous drug use. However, the absence 
of such associations may be due to the low prevalence of 
anti-HBc, resulting in wide 95% CIs and ORs; thus, the 
presence of moderate associations should not be ruled out.
Regarding the absence of positive anti-HCV found 
in the present study, although this absence represents a 
good perspective regarding hepatitis C infection in the 
future for this population, this result was not surprising 
based on the most common modes of HCV transmission 
and the age of the studied population. Other studies carried 
out in Brazil found zero prevalence (Voigt et al., 2009) and 
very low anti-HCV prevalence, similar to studies carried 
out in developed countries such as England and Wales 
(0.61%) (Balogun et al., 2002).
We acknowledge that there are some limitations to 
our analysis. Certain caution is necessary when extrapo-
lating these findings to the target population, although 
our findings were fairly similar to other studies within the 
country and, more specifically, within this same region. 
Additionally, because the answers about risk factors were 
collected by self-administered questionnaires that included 
questions regarding illicit and “inadequate” habits, such 
results may have been underestimated.
Despite the above limitations, the results of this 
study point to the continuous progress toward the eradica-
tion of HBV transmission in south Brazil through universal 
immunization, with special attention given to the “catch 
up” immunization of non-vaccinated adolescents. This 
“catch up” immunization may have played a key role in 
guarantying the current low infection rates in these South 
Brazilian young adults who were born two or three years 
before the implementation of hepatitis B vaccination in this 
state, in agreement with the cohort effect of successfully 
immunizing infants and adolescents suggested by Koya, 
Hill, Darden (2008). This trend allows us to foresee a pro-
gressive continuous decrease in HBV circulation, which 
may lead to a fully immunized population followed by a 
consequently decrease in hospitalization and treatment 
expenses regarding HBV and thus a possible redirection 
of public health funds to treat less preventable diseases. 
Accordingly, this change in the HBV scenario may occur 
faster and more effectively if all adults are successfully 
immunized, which suggests a need to re-evaluate current 
vaccination strategies to determine whether to include 
a wider age range that includes adults and to formulate 
strategies to guarantee infant and adolescent vaccination 
through mandatory policies, which have been proven to 
be effective in other countries.
This study demonstrated, for the first time, the 
hepatitis B and C profile of a young adult population in 
the MRF, South Brazil. This population was born prior 
to the establishment of the hepatitis B vaccination in this 
region and has distinct characteristics in comparison to the 
general adult Brazilian population, based on the very low 
anti-HBc prevalence of markers of infection and risks fac-
tors. This profile, which is very similar to that of developed 
countries where hepatitis B vaccination has been fully and 
successfully implemented, indicates a very optimistic situ-
ation with respect to the HBV and HCV infection rate in 
the future for this population. Furthermore, it highlights 
the effectiveness of the National Immunization Program 
Protocol for hepatitis B and the great importance of main-
taining education and awareness campaigns for disease 
prevention through safe sexual behavior, among others. 
Further investigation should examine the vaccination 
coverage and immunity in this population and provide 
more data to guide the needed changes in the current im-
munization policies.
ACKNOWLEDGEMENTS
The present study was supported by the National 
Council for Scientific and Technological Development – 
CNPq – Brazil.
The authors would like to thank the Air Base of 
Florianópolis and the Hemocenter and the Laboratory of 
the University Hospital of the Federal University of Santa 
Catarina for their support.
REFERENCES
ANTUNES, H.; MACEDO, M.; ESTRADA, A. Taxa de 
cobertura vacinal com imunização para o vírus da hepatite 
B. Acta Med. Port., v.17, p.303-308, 2004.
Seroprevalence of HBV and HCV markers among young adult males in the Air Force in Florianópolis, South Brazil 263
BALOGUN, M.A.; RAMSAY, M.E.; HESKETH, L.M.; 
ANDREWS, N.; OSBORNE, K.P.; GAY, N.J.; MORGAN-
CAPNER, P. The prevalence of hepatitis C in England and 
Wales. J. Infect., v.45, p.219-226, 2002.
BUT, D.Y.; LAI, C.L.; LIM, W.L.; FUNG, J.; WONG, D.K.; 
YUEN, M.F. Twenty-two years follow-up of a prospective 
randomized trial of hepatitis B vaccines without booster 
dose in children: final report. Vaccine, v.26, p.6587-6591, 
2008.
FABRIS, P.; BALDO, V.; BALDOVIN, T. BELLOTTO, E.; 
RASSU, M.; TRIVELLO, R.; TRAMARIN, A.; TOSITTI, 
G.; FLOREANI, A. Changing Epidemiology of HCV and 
HBV Infections in Northern Italy: A Survey in the General 
Population. J. Clin. Gastroenterol., v.42, p.527-532, 2008.
GERMAN, V.; GIANNAKOS, G.; KOPTERIDES, P.; 
LIASKONIS, K.; FALAGAS, M.E. Serologic indices of 
hepatitis B virus infection in military recruits in Greece 
(2004-2005). BMC Infect. Dis., v.6, p.163, 2006.
HAMMITT, L.L; HENNESSY, T.W.; FIORE, A.E.; ZANIS, 
C.; HUMMEL, K.B.; DUNAWAY, E.; BULKOW, L.; 
MCMAHON, B.J. Hepatitis B immunity in children 
vaccinated with recombinant hepatitis B vaccine beginning 
at birth: a follow-up study at 15 years. Vaccine, v.25, p.6958-
6964, 2007.
KNOLL, A.; HARTMANN, A.; HAMOSHI, H.; WEISLMAIER, 
K.; JILG, W. Serological pattern “anti-HBc alone”: 
characterization of 552 individuals and clinical significance. 
World J. Gastroenterol., v.28, p.1255-1260, 2006.
KOYA, D.L.; HILL, E.G.; DARDEN, P.M. The effect of 
vaccinated children on increased hepatitis B immunization 
among high-risk adults. Am. J. Public Health, v.98, p.832-
838, 2008.
MARTELLI, C.M.; TURCHI, M.; SOUTO, F.J.; SAEZ-
ALQUEZAR, A.; ANDRADE, A.L.; ZICKER, F. Anti-
HBc testing for blood donations in areas with intermediate 
hepatitis B endemicity. Rev. Panam. Salud Publica, v.6, 
p.69-73, 1999.
MCQUILLAN, G.M.; COLEMAN, P.J.; KRUSZON-MORAN, 
D.; MOYER, L.A.; LAMBERT, S.B.; MARGOLIS, H.S. 
Prevalence of hepatitis B virus infection in the United 
States: the National Health and Nutrition Examination 
Surveys, 1976 through 1994. Am. J. Public Health, v.89, 
p.14-18, 1999.
MINISTÉRIO DA SAÚDE. Hepatites virais: O Brasil está 
atento. 3.ed. Brasília, DF: Ministério da Saúde, 2008. 60p.
MINISTÉRIO DA SAÚDE. Programa nacional de imunizações: 
PNI 30 anos. Brasília, DF: Fundação Nacional de Saúde, 
2003. 208p.
MOTTA, V.T.; WAGNER, M.B. Bioestatística. Caxias do Sul: 
Educs; São Paulo: Robe Editorial, 2003. 201p.
NASCIMENTO, M.C.; MAYAUD, P.; SABINO, E.C.; TORRES, 
K.L., FRANCESCHI, S. Prevalence of hepatitis B and C 
serological markers among first-time blood donors in Brazil: 
a multi-center serosurvey. J. Med. Virol., v.80, p.53-57, 2008.
PEREIRA, L.M.M.B.; MARTELLI, C.M.T.; MERCHÁN-
HAMANN, E.; MONTARROYOS, U.R.; BRAGA, M.C.; 
LIMA, M.L.C.; CARDOSO, M.R.A.; TURCHI, M.D.; 
COSTA, M.A.; ALENCAR, L.C.A.; MOREIRA, R.C.; 
FIGUEIREDO, G.M.; XIMENES, R.A.A. Population-
based multicentric survey of hepatitis B infection and risk 
factor differences among three regions in Brazil. Am. J. 
Trop. Med. Hyg., v.81, p.240-247, 2009.
ROSINI, N.; MOUSSE, D.; SPADA, C.; TREITINGER, A. 
Seroprevelence of HbsAg, anti-HBc and anti-HCV in 
Southern Brazil, 1999-2001. Braz. J. Infect. Dis., v.7, 
p.262-267, 2003.
SCARAVELI,  N.G.;  PASSOS, A.M.;  VOIGT, A.R.; 
LIVRAMENTO, A.; TONIAL, G.; TREITINGER, A.; 
SPADA, C. Seroprevalence of hepatitis B and hepatitis 
C markers in adolescents in Southern Brazil. Cad. Saúde 
Pública, v.27, p.753-758, 2011.
SCOTT, P.T.; NIEBUHR, D.W.; MCGREADY, J.B.; GAYDOS, 
J.C. Hepatitis B immunity in United States military recruits. 
J. Infect. Dis., v.191, p.1835-1841, 2005.
TOLEDO, A.C.; GRECO, D.B.; FELGA, M.; BARREIRA, D.; 
GADELHA, M.D.E.; SPERANZA, F.A. Seroprevalence 
of hepatitis B and C in Brazilian army conscripts in 2002: a 
cross-sectional study. Braz. J. Infect. Dis., v.9, p.374-383, 2005.
TONIAL,  G. ;  PASSOS,  A.M.;  LIVRAMENTO, A. ; 
SCARAVELI, N.G.; BATSCHAUER, A.P.B.; BUENO, 
E.C.; LARGURA, A.; SPADA, C.; TREITINGER, 
A. Hepatitis B marker seroprevalence and vaccination 
coverage in adolescents in the City of Itajaí, State of Santa 
Catarina, Southern Brazil, in 2008. Rev. Soc. Bras. Med. 
Trop., v.44, p.416-419, 2011.
A. M. Passos, M. Strazer Neto, A. Treitinger, C. Spada264
VOIGT,  A.R. ;  STRAZER NETO,  M. ;  SPADA,  C. ; 
TREITINGER, A. Seroprevalence of hepatitis B and 
hepatitis C markers amon children and adolescentes 
in the South Brazilian Region – Metropolitan Area of 
Florianópolis, Santa Catarina. Braz. J. Infect. Dis., v.14, 
p.60-65, 2010.
WORLD HEALTH ORGANIZATION. Global distribution of 
hepatitis A, B and C, 2001. Wkly. Epidemiol. Rec., v.77, 
p.46-47, 2002.
WORLD HEALTH ORGANIZATION. Hepatitis B vaccines. 
Wkly. Epidemiol. Rec., v.84, p.405-420, 2009.
WORLD HEALTH ORGANIZATION. Hepatitis C – global 
prevalence (update). Wkly. Epidemiol. Rec., v.74, p.425-
427, 1999.
XIMENES, R.A.A.; PEREIRA, L.M.B.; MERTELLI, C.M.T.; 
MERCHÁN-HAMANN, E.; STEIN, A.T.; FIGUEIREDO, 
G.M.; BRAGA, M.C.; MONTARROYOS, U.R.; BRASIL, 
L.M.; TURCHI, M.D.; FONSECA, J.C.F.; LIMA, M.L.C.; 
ALENCAR, L.C.A.; COSTA, M.; CORAL, G.; MOREIRA, 
R.C.; CARDOSO, M.R.A. Methodology of a nationwide 
cross-sectional survey of prevalence and epidemiological 
patterns of hepatitis A, B and C infection in Brazil. Cad. 
Saúde Pública, v.26, p.1693-1704, 2010.
ZANETTI, A.R.; MARIANO, A.; ROMANÒ, L.; D’AMELIO, 
R.; CHIRONNA, M.; COPPOLA, R.C.; CUCCIA, 
M.; MANGIONE, R.; MARRONE, F.; NEGRONE, 
F.S.;  PARLATO, A.; ZAMPARO, E.; ZOTTI, C.; 
STROFFOLINI, T.; MELE, A. Long-term immunogenicity 
of hepatitis B vaccination and policy for booster: an Italian 
multicentre study. Lancet, v.366, p.1379-1384, 2005.
Received for publication on 14th July 2011
Accepted for publication on 06th March 2012
